Submission Details
| 510(k) Number | K170065 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 09, 2017 |
| Decision Date | March 09, 2017 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K170065 is an FDA 510(k) clearance for the ADVIA? Chemistry Total Bilirubin_2 (TBIL_2), a Enzymatic Method, Bilirubin (Class II — Special Controls, product code JFM), submitted by Siemens Healthcare Diagnostics, Inc. (New York, US). The FDA issued a Cleared decision on March 9, 2017, 59 days after receiving the submission on January 9, 2017. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1110.
| 510(k) Number | K170065 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 09, 2017 |
| Decision Date | March 09, 2017 |
| Days to Decision | 59 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JFM — Enzymatic Method, Bilirubin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1110 |